Giovanni F. Pellicano
Messina, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Feasibility and safety of recombinant zoster vaccination in patients undergoing active cancer treatments: A real-world single-center experience.
Journal: Human vaccines & immunotherapeutics
Published: July 30, 2026
Changing renal profile and early eGFR dynamics after ART initiation or switch in a large Italian HIV cohort.
Journal: Frontiers in medicine
Published: June 02, 2026
Distance from low-density lipoprotein cholesterol targets across cardiovascular risk strata in people living with HIV: A multicentre cohort study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 14, 2026
Efficacy and Safety of Cabotegravir-Rilpivirine in PLWH: A Real-World Study.
Journal: Viruses
Published: October 01, 2025
Investigating the Impact of Fusobacterium nucleatum on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical Trial.
Journal: International journal of molecular sciences
Published: June 24, 2025
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation.
Journal: Pathogens (Basel, Switzerland)
Published: May 20, 2025
Real-world effectiveness and safety of cefiderocol in critically ill patients with MDR Gram-negative infections: Results from a retrospective study.
Journal: Biomedical reports
Published: May 13, 2025
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study.
Journal: BMC infectious diseases
Published: February 27, 2025
The Challenging Scenario of Cancer Treatment for People with HIV: Clinical Experience with Immune Checkpoint Inhibitors.
Journal: Current oncology (Toronto, Ont.)
Published: January 01, 2025
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple Regimen.
Journal: AIDS research and treatment
Published: September 26, 2024
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort.
Journal: Biomedicines
Published: August 29, 2024
Enhanced metabolic health and immune response with bictegravir/emtricitabine/TAF: Insights from a 96‑week retrospective study.
Journal: Biomedical reports
Published: August 01, 2024
Last Updated: 09/26/2026